基于模拟CT的影像组学预测局部进展期直肠癌新辅助放化疗后反应
双中心回顾性分析纳入201例局部进展期直肠腺癌患者,从模拟CT勾画的直肠大体肿瘤体积中提取1150个特征,构建5个主成分特征联合5近邻模型。探索队列预测病理良好反应的平均AUC为0.65±0.02,外部验证队列AUC为0.63,两队列良好反应率分别为46%和54.7%(p=0.247)。
要点
- 基于模拟CT的影像组学特征联合5近邻模型在探索队列预测病理良好反应的平均AUC为0.65±0.02。
- 该模型在外部验证队列中AUC为0.63,预测能力略低但精度相似。
- 探索队列与外部验证队列的病理良好反应率分别为46%和54.7%(p=0.247)。
核心结论
- 基于模拟CT的影像组学数据挖掘在两个独立队列中可行且可重复,对新辅助放化疗反应的预测具有中等精度。
研究设计与样本
- 共纳入201例患者,其中探索队列126例(62.7%),外部验证队列75例(37.3%)。
- 在模拟CT上手动勾画直肠大体肿瘤体积,经特征筛选后使用自主开发的软件(基于Python 3.6编写)提取可挖掘数据。
- 模型选择与超参数化采用五折交叉验证方法。
- 主要结局指标为病理良好反应率,定义为根据Dworak分类的肿瘤 regression grade(TRG)3和4之和。
主要发现
- 两队列患者特征均衡,病理良好反应率分别为探索队列46%、外部验证队列54.7%(p=0.247)。
- 从计划扫描中共提取1150个特征。
- 由主成分分析聚类(主要成分包括LHL灰度大小区域:大区域强调、伸长率、HHH强度直方图均值、HLL游程长度:游程水平方差和HHH共现:聚类趋势)联合5近邻模型构成的5个元特征复合体是最稳健的特征签名。
- 应用于探索队列时,预测病理良好反应的平均AUC为0.65±0.02。
- 在外部验证队列测试时,预测精度相似但预测能力略低,AUC为0.63。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To report on the discriminative ability of a simulation Computed Tomography (CT)-based radiomics signature for predicting response to treatment in patients undergoing neoadjuvant chemo-radiation for locally advanced adenocarcinoma of the rectum. METHODS: Consecutive patients treated at the Universities of Tübingen (from 1/1/07 to 31/12/10, explorative cohort) and Florence (from 1/1/11 to 31/12/17, external validation cohort) were considered in our dual-institution, retrospective analysis. Long-course neoadjuvant chemo-radiation was performed according to local policy. On simulation CT, the rectal Gross Tumor Volume was manually segmented. A feature selection process was performed yielding mineable data through an in-house developed software (written in Python 3.6). Model selection and hyper-parametrization of the model was performed using a fivefold cross validation approach. The main outcome measure of the study was the rate of pathologic good response, defined as the sum of Tumor regression grade (TRG) 3 and 4 according to Dworak's classification. RESULTS: Two-hundred and one patients were included in our analysis, of whom 126 (62.7%) and 75 (37.3%) cases represented the explorative and external validation cohorts, respectively. Patient characteristics were well balanced between the two groups. A similar rate of good response to neoadjuvant treatment was obtained in in both cohorts (46% and 54.7%, respectively; p = 0.247). A total of 1150 features were extracted from the planning scans. A 5-metafeature complex consisting of Principal component analysis (PCA)-clusters (whose main components are LHL Grey-Level-Size-Zone: Large Zone Emphasis, Elongation, HHH Intensity Histogram Mean, HLL Run-Length: Run Level Variance and HHH Co-occurence: Cluster Tendency) in combination with 5-nearest neighbour model was the most robust signature. When applied to the explorative cohort, the prediction of good response corresponded to an average Area under the curve (AUC) value of 0.65 ± 0.02. When the model was tested on the external validation cohort, it ensured a similar accuracy, with a slightly lower predictive ability (AUC of 0.63). CONCLUSIONS: Radiomics-based, data-mining from simulation CT scans was shown to be feasible and reproducible in two independent cohorts, yielding fair accuracy in the prediction of response to neoadjuvant chemo-radiation.
引用
- Bonomo P, Socarras Fernandez J, Thorwarth D, et al. Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer. Radiat Oncol. 2022. PMID: 35484597. doi:10.1186/s13014-022-02053-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。